Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Bacitracin

A polypeptide antibiotic produced by the bacterium Bacillus licheniformis, isolated in 1945 at Columbia University in New York and approved in 1948; it is used mainly in ointments and eye drops for skin and eye infections. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.

Did you know?The name combines Bacillus and Tracy, the name the researchers gave the strain in honour of a young patient: it was isolated from tissue taken from her open fracture of the tibia.

BacitracinGo to the active ingredient →
BacitracinActive ingredientBacitracinCat. No. P-B001-001CAS 1405-87-4
Bacitracin AActive ingredientBacitracin ACat. No. P-B001-026CAS 22601-59-8

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.